nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.01.2019 | Neurorehabilitation and Recovery (J Krakauer and T Kitago, Section Editors)

Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies

verfasst von: Ania Dabrowski, Thomas J. Robinson, Ryan J. Felling

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

After decades of hype, cell-based therapies are emerging into the clinical arena for the purposes of promoting recovery after stroke. In this review, we discuss the most recent science behind the role of cell-based therapies in ischemic stroke and the efforts to translate these therapies into human clinical trials.

Recent Findings

Preclinical data support numerous beneficial effects of cell-based therapies in both small and large animal models of ischemic stroke. These benefits are driven by multifaceted mechanisms promoting brain repair through immunomodulation, trophic support, circuit reorganization, and cell replacement.

Summary

Cell-based therapies offer tremendous potential for improving outcomes after stroke through multimodal support of brain repair. Based on recent clinical trials, cell-based therapies appear both feasible and safe in all phases of stroke. Ongoing translational research and clinical trials will further refine these therapies and have the potential to transform the approach to stroke recovery and rehabilitation.

Ramon y Cajal S. Degeneration and regeneration of the nervous system. London: Oxford University Press; 1928.

Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255(5052):1707–10.CrossRefPubMed

Ramalho-Santos M, Willenbring H. On the origin of the term "stem cell". Cell Stem Cell. 2007;1(1):35–8. https://doi.org/10.1016/j.stem.2007.05.013.CrossRefPubMed

Quesenberry PJ, Colvin G, Dooner G, Dooner M, Aliotta JM, Johnson K. The stem cell continuum: cell cycle, injury, and phenotype lability. Ann N Y Acad Sci. 2007;1106:20–9. https://doi.org/10.1196/annals.1392.016.CrossRefPubMed

Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008;100:133–58. https://doi.org/10.1016/S0065-230X(08)00005-5.CrossRefPubMed

Kawai H, Yamashita T, Ohta Y, Deguchi K, Nagotani S, Zhang X, et al. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab. 2010;30(8):1487–93. https://doi.org/10.1038/jcbfm.2010.32.CrossRefPubMedPubMedCentral

Chen SJ, Chang CM, Tsai SK, Chang YL, Chou SJ, Huang SS, et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 2010;19(11):1757–67. https://doi.org/10.1089/scd.2009.0452.CrossRefPubMed

Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.CrossRefPubMed

Ilic D, Ogilvie C. Concise review: human embryonic stem cells-what have we done? What are we doing? Where are we going? Stem Cells. 2017;35(1):17–25. https://doi.org/10.1002/stem.2450.CrossRefPubMed

10.

Ware CB. Concise review: lessons from naive human pluripotent cells. Stem Cells. 2017;35(1):35–41. https://doi.org/10.1002/stem.2507.CrossRefPubMed

11.

Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab. 2003;23(7):780–5. https://doi.org/10.1097/01.WCB.0000071886.63724.FB.CrossRefPubMed

12.

Peljto M, Wichterle H. Programming embryonic stem cells to neuronal subtypes. Curr Opin Neurobiol. 2011;21(1):43–51. https://doi.org/10.1016/j.conb.2010.09.012.CrossRefPubMed

13.

Gaspard N, Vanderhaeghen P. Mechanisms of neural specification from embryonic stem cells. Curr Opin Neurobiol. 2010;20(1):37–43. https://doi.org/10.1016/j.conb.2009.12.001.CrossRefPubMed

14.

Elkabetz Y, Studer L. Human ESC-derived neural rosettes and neural stem cell progression. Cold Spring Harb Symp Quant Biol. 2008;73:377–87. https://doi.org/10.1101/sqb.2008.73.052.CrossRefPubMed

15.

Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci. 2009;29(3):562–74. https://doi.org/10.1111/j.1460-9568.2008.06599.x.CrossRefPubMed

16.

Buhnemann C, Scholz A, Bernreuther C, Malik CY, Braun H, Schachner M, et al. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain. 2006;129(Pt 12):3238–48. https://doi.org/10.1093/brain/awl261.CrossRefPubMed

17.

Daadi MM, Maag AL, Steinberg GK. Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One. 2008;3(2):e1644. https://doi.org/10.1371/journal.pone.0001644.CrossRefPubMedPubMedCentral

18.

Hayashi J, Takagi Y, Fukuda H, Imazato T, Nishimura M, Fujimoto M, et al. Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab. 2006;26(7):906–14. https://doi.org/10.1038/sj.jcbfm.9600247.CrossRefPubMed

19.

Gage FH. Neurogenesis in the adult brain. J Neurosci. 2002;22(3):612–3.CrossRefPubMedPubMedCentral

20.

Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97(6):703–16.CrossRefPubMed

21.

Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol. 2009;117(5):469–80. https://doi.org/10.1007/s00401-009-0516-1.CrossRefPubMed

22.

Noisa P, Urrutikoetxea-Uriguen A, Li M, Cui W. Generation of human embryonic stem cell reporter lines expressing GFP specifically in neural progenitors. Stem Cell Rev. 2010;6(3):438–49. https://doi.org/10.1007/s12015-010-9159-9.CrossRef

23.

Bond AM, Ming GL, Song H. Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell. 2015;17(4):385–95. https://doi.org/10.1016/j.stem.2015.09.003.CrossRefPubMedPubMedCentral

24.

•• Larimer P, Spatazza J, Espinosa JS, Tang Y, Kaneko M, Hasenstaub AR, et al. Caudal Ganglionic Eminence Precursor Transplants Disperse and Integrate as Lineage-Specific Interneurons but Do Not Induce Cortical Plasticity. Cell Rep. 2016;16(5):1391–404. https://doi.org/10.1016/j.celrep.2016.06.071 The authors demonstrate that not all neural precursor cells have equal capacity to induce neuroplasticity. Following transplantation, precursor cells from both the medial and caudal ganglionic emincences disperse throughout the brain and laminate appropriately as interneurons. The ability to induce ocular dominance plasticity is restricted to genetically specified “medial” precurors even if isolated anatomically from the caudal ganglionic eminence. CrossRefPubMedPubMedCentral

25.

Chen L, Zhang G, Gu Y, Guo X. Meta-analysis and systematic review of neural stem cells therapy for experimental ischemia stroke in preclinical studies. Sci Rep. 2016;6:32291. https://doi.org/10.1038/srep32291.CrossRefPubMedPubMedCentral

26.

Huang H, Qian K, Han X, Li X, Zheng Y, Chen Z, et al. Intraparenchymal neural stem/progenitor cell transplantation for ischemic stroke animals: a meta-analysis and systematic review. Stem Cells Int. 2018;2018:4826407–10. https://doi.org/10.1155/2018/4826407.CrossRefPubMedPubMedCentral

27.

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294–301. https://doi.org/10.1634/stemcells.2005-0342.CrossRefPubMed

28.

Banerjee S, Williamson DA, Habib N, Chataway J. The potential benefit of stem cell therapy after stroke: an update. Vasc Health Risk Manag. 2012;8:569–80. https://doi.org/10.2147/VHRM.S25745.CrossRefPubMedPubMedCentral

29.

Greco SJ, Zhou C, Ye JH, Rameshwar P. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev. 2007;16(5):811–26. https://doi.org/10.1089/scd.2007.0011.CrossRefPubMed

30.

Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2):247–56. https://doi.org/10.1006/exnr.2000.7389.CrossRefPubMed

31.

Dezawa M. Muse cells provide the pluripotency of mesenchymal stem cells: direct contribution of Muse cells to tissue regeneration. Cell Transplant. 2016;25(5):849–61. https://doi.org/10.3727/096368916X690881.CrossRefPubMed

32.

Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A. 2010;107(19):8639–43. https://doi.org/10.1073/pnas.0911647107.CrossRefPubMedPubMedCentral

33.

• Yamauchi T, Kuroda Y, Morita T, Shichinohe H, Houkin K, Dezawa M, et al. Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PloS One. 2015;10(3):e0116009. https://doi.org/10.1371/journal.pone.0116009 This study demonstrates possible independent effects and mechanisms for different subpopulations of bone marrow derived progenitors in stroke recovery. CrossRefPubMedPubMedCentral

34.

Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815–22. https://doi.org/10.1182/blood-2004-04-1559.CrossRefPubMed

35.

Hess DC, Hill WD. Cell therapy for ischaemic stroke. Cell Prolif. 2011;44(Suppl 1):1–8. https://doi.org/10.1111/j.1365-2184.2010.00718.x.CrossRefPubMedPubMedCentral

36.

Rosado-de-Castro PH, Schmidt Fda R, Battistella V. Lopes de Souza SA, Gutfilen B, Goldenberg RC et al. biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen Med. 2013;8(2):145–55. https://doi.org/10.2217/rme.13.2.CrossRefPubMed

37.

Jiang J, Wang Y, Liu B, Chen X, Zhang S. Challenges and research progress of the use of mesenchymal stem cells in the treatment of ischemic stroke. Brain Dev. 2018;40:612–26. https://doi.org/10.1016/j.braindev.2018.03.015.CrossRefPubMed

38.

Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–20. https://doi.org/10.1126/science.1151526.CrossRefPubMed

39.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72. https://doi.org/10.1016/j.cell.2007.11.019.CrossRefPubMed

40.

Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28(8):848–55. https://doi.org/10.1038/nbt.1667.CrossRefPubMedPubMedCentral

41.

Han X, Yu L, Ren J, Wang M, Liu Z, Hu X, et al. Efficient and fast differentiation of human neural stem cells from human embryonic stem cells for cell therapy. Stem Cells Int. 2017;2017:9405204–11. https://doi.org/10.1155/2017/9405204.CrossRefPubMedPubMedCentral

42.

Denham M, Dottori M. Neural differentiation of induced pluripotent stem cells. Methods Mol Biol. 2011;793:99–110. https://doi.org/10.1007/978-1-61779-328-8_7.CrossRefPubMed

43.

Marei HE, Hasan A, Rizzi R, Althani A, Afifi N, Cenciarelli C, et al. Potential of stem cell-based therapy for ischemic stroke. Front Neurol. 2018;9:34. https://doi.org/10.3389/fneur.2018.00034.CrossRefPubMedPubMedCentral

44.

Kokaia Z, Llorente IL, Carmichael ST. Customized brain cells for stroke patients using pluripotent stem cells. Stroke. 2018;49(5):1091–8. https://doi.org/10.1161/STROKEAHA.117.018291.CrossRefPubMedPubMedCentral

45.

• Kokaia Z, Tornero D, Lindvall O. Transplantation of reprogrammed neurons for improved recovery after stroke. Prog Brain Res. 2017;231:245–63. https://doi.org/10.1016/bs.pbr.2016.11.013 The authors provide a comprehensive review of iPSC-derived precursors for stroke recovery. CrossRefPubMed

46.

Chau MJ, Deveau TC, Song M, Gu X, Chen D, Wei L. iPSC transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats. Stem Cells. 2014;32(12):3075–87. https://doi.org/10.1002/stem.1802.CrossRefPubMed

47.

Oki K, Tatarishvili J, Wood J, Koch P, Wattananit S, Mine Y, et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells. 2012;30(6):1120–33. https://doi.org/10.1002/stem.1104.CrossRefPubMed

48.

Tornero D, Wattananit S, Gronning Madsen M, Koch P, Wood J, Tatarishvili J, et al. Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain. 2013;136(Pt 12):3561–77. https://doi.org/10.1093/brain/awt278.CrossRefPubMed

49.

•• Tornero D, Tsupykov O, Granmo M, Rodriguez C, Gronning-Hansen M, Thelin J, et al. Synaptic inputs from stroke-injured brain to grafted human stem cell-derived neurons activated by sensory stimuli. Brain. 2017;140(3):692–706. https://doi.org/10.1093/brain/aww347 The authors demonstrate that iPSC-derived cortically primed neurons engraft and receive direct synaptic inputs from host thalamic neurons. This occurs in a somatotopic fashion, and transplanted neurons can exhibit activation from physiological stimuli. CrossRefPubMed

50.

Altman J. Are new neurons formed in the brains of adult mammals? Science. 1962;135(3509):1127–8.CrossRefPubMed

51.

Kaplan MS, Hinds JW. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science. 1977;197(4308):1092–4.CrossRefPubMed

52.

Ihrie RA, Alvarez-Buylla A. Lake-front property: a unique germinal niche by the lateral ventricles of the adult brain. Neuron. 2011;70(4):674–86. https://doi.org/10.1016/j.neuron.2011.05.004.CrossRefPubMedPubMedCentral

53.

Bonaguidi MA, Song J, Ming GL, Song H. A unifying hypothesis on mammalian neural stem cell properties in the adult hippocampus. Curr Opin Neurobiol. 2012;22(5):754–61. https://doi.org/10.1016/j.conb.2012.03.013.CrossRefPubMedPubMedCentral

54.

Rakic P. Limits of neurogenesis in primates. Science. 1985;227(4690):1054–6.CrossRefPubMed

55.

Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4(11):1313–7. https://doi.org/10.1038/3305.CrossRefPubMed

56.

Bhardwaj RD, Curtis MA, Spalding KL, Buchholz BA, Fink D, Bjork-Eriksson T, et al. Neocortical neurogenesis in humans is restricted to development. Proc Natl Acad Sci U S A. 2006;103(33):12564–8. https://doi.org/10.1073/pnas.0605177103.CrossRefPubMedPubMedCentral

57.

• Paredes MF, James D, Gil-Perotin S, Kim H, Cotter JA, Ng C et al. Extensive migration of young neurons into the infant human frontal lobe. Science. 2016;354(6308):81–88. doi:https://doi.org/10.1126/science.aaf7073. This study demonstrates a previously unappreciated persistence of neurogenesis and migration in the postnatal human brain, albeit largely limited to infants.

58.

Felling RJ, Snyder MJ, Romanko MJ, Rothstein RP, Ziegler AN, Yang Z, et al. Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci. 2006;26(16):4359–69. https://doi.org/10.1523/JNEUROSCI.1898-05.2006.CrossRefPubMedPubMedCentral

59.

Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002;8(9):963–70. https://doi.org/10.1038/nm747.CrossRefPubMed

60.

Plane JM, Liu R, Wang TW, Silverstein FS, Parent JM. Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis. 2004;16(3):585–95. https://doi.org/10.1016/j.nbd.2004.04.003.CrossRefPubMed

61.

Parent JM. The role of seizure-induced neurogenesis in epileptogenesis and brain repair. Epilepsy Res. 2002;50(1–2):179–89.CrossRefPubMed

62.

Lindvall O, Kokaia Z. Neurogenesis following Stroke Affecting the Adult Brain. Cold Spring Harb Perspect Biol. 2015;7(11):1–19. doi:https://doi.org/10.1101/cshperspect.a019034.

63.

Felling RJ, Levison SW. Enhanced neurogenesis following stroke. J Neurosci Res. 2003;73(3):277–83. https://doi.org/10.1002/jnr.10670.CrossRefPubMed

64.

Lagace DC. Does the endogenous neurogenic response alter behavioral recovery following stroke? Behav Brain Res. 2012;227(2):426–32. https://doi.org/10.1016/j.bbr.2011.08.045.CrossRefPubMed

65.

Jin K, Wang X, Xie L, Mao XO, Zhu W, Wang Y, et al. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A. 2006;103(35):13198–202. https://doi.org/10.1073/pnas.0603512103.CrossRefPubMedPubMedCentral

66.

Marti-Fabregas J, Romaguera-Ros M, Gomez-Pinedo U, Martinez-Ramirez S, Jimenez-Xarrie E, Marin R, et al. Proliferation in the human ipsilateral subventricular zone after ischemic stroke. Neurology. 2010;74(5):357–65. https://doi.org/10.1212/WNL.0b013e3181cbccec.CrossRefPubMed

67.

Lam J, Lowry WE, Carmichael ST, Segura T. Delivery of iPS-NPCs to the stroke cavity within a hyaluronic acid matrix promotes the differentiation of transplanted cells. Adv Funct Mater. 2014;24(44):7053–62. https://doi.org/10.1002/adfm.201401483.CrossRefPubMedPubMedCentral

68.

George PM, Oh B, Dewi R, Hua T, Cai L, Levinson A, et al. Engineered stem cell mimics to enhance stroke recovery. Biomaterials. 2018;178:63–72. https://doi.org/10.1016/j.biomaterials.2018.06.010.CrossRefPubMedPubMedCentral

69.

•• Cook DJ, Nguyen C, Chun HN, I LL, Chiu AS, Machnicki M, et al. Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke. J Cereb Blood Flow Metab. 2017;37(3):1030–45. https://doi.org/10.1177/0271678X16649964 This study demonstrates the potential for hydrogel scaffolds to promote endogenous repair mechanisms including neurogenesis. CrossRefPubMed

70.

Moshayedi P, Nih LR, Llorente IL, Berg AR, Cinkornpumin J, Lowry WE, et al. Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials. 2016;105:145–55. https://doi.org/10.1016/j.biomaterials.2016.07.028.CrossRefPubMedPubMedCentral

71.

Manley NC, Steinberg GK. Tracking stem cells for cellular therapy in stroke. Curr Pharm Des. 2012;18(25):3685–93.CrossRefPubMedPubMedCentral

72.

Walczak P, Wojtkiewicz J, Nowakowski A, Habich A, Holak P, Xu J, et al. Real-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous system. J Cereb Blood Flow Metab. 2017;37(7):2346–58. https://doi.org/10.1177/0271678X16665853.CrossRefPubMed

73.

Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39(5):1569–74. https://doi.org/10.1161/STROKEAHA.107.502047.CrossRefPubMedPubMedCentral

74.

Janowski M, Walczak P, Kropiwnicki T, Jurkiewicz E, Domanska-Janik K, Bulte JW, et al. Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF. PLoS One. 2014;9(2):e97631. https://doi.org/10.1371/journal.pone.0097631.CrossRefPubMedPubMedCentral

75.

Janowski M, Wagner DC, Boltze J. Stem cell-based tissue replacement after stroke: factual necessity or notorious fiction? Stroke. 2015;46(8):2354–63. https://doi.org/10.1161/STROKEAHA.114.007803.CrossRefPubMedPubMedCentral

76.

Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13(4):661–70. https://doi.org/10.1007/s13311-016-0483-x.CrossRefPubMedPubMedCentral

77.

Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, Grigoriadis N. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci. 2003;24(3):623–31.CrossRefPubMed

78.

Erlandsson A, Lin CH, Yu F, Morshead CM. Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury. Exp Neurol. 2011;230(1):48–57. https://doi.org/10.1016/j.expneurol.2010.05.018.CrossRefPubMed

79.

Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience. 2009;158(3):1021–9. https://doi.org/10.1016/j.neuroscience.2008.06.052.CrossRefPubMed

80.

Thored P, Heldmann U, Gomes-Leal W, Gisler R, Darsalia V, Taneera J, et al. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia. 2009;57(8):835–49. https://doi.org/10.1002/glia.20810.CrossRefPubMed

81.

Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, et al. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11(1):56–64. https://doi.org/10.1038/nrneurol.2014.207.CrossRefPubMed

82.

• Ma Y, Wang J, Wang Y, Yang GY. The biphasic function of microglia in ischemic stroke. Prog Neurobiol. 2017;157:247–72. https://doi.org/10.1016/j.pneurobio.2016.01.005 The authors nicely review the dual functions of inflammation, in particularly microglia, in mediating both stroke-related injury and repair. CrossRefPubMed

83.

Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A. 2008;105(38):14638–43. https://doi.org/10.1073/pnas.0803670105.CrossRefPubMedPubMedCentral

84.

Boshuizen MCS, Steinberg GK. Stem cell-based immunomodulation after stroke: effects on brain repair processes. Stroke. 2018;49(6):1563–70. https://doi.org/10.1161/STROKEAHA.117.020465.CrossRefPubMedPubMedCentral

85.

•• Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(5):360–8. https://doi.org/10.1016/S1474-4422(17)30046-7 This is one of the more extensive and rigorously designed trials of cell-based therapy. While efficacy outcomes were not significantly positive, the study demonstrates the feasibility of cell-based therapy in a very acute window utilizing an “off the shelf” cell product. CrossRefPubMed

86.

Yang B, Hamilton JA, Valenzuela KS, Bogaerts A, Xi X, Aronowski J, et al. Multipotent adult progenitor cells enhance recovery after stroke by modulating the immune response from the spleen. Stem Cells. 2017;35(5):1290–302. https://doi.org/10.1002/stem.2600.CrossRefPubMed

87.

Yang B, Li W, Satani N, Nghiem DM, Xi X, Aronowski J, et al. Protective effects of autologous bone marrow mononuclear cells after administering t-PA in an embolic stroke model. Transl Stroke Res. 2018;9(2):135–45. https://doi.org/10.1007/s12975-017-0563-1.CrossRefPubMed

88.

Stonesifer C, Corey S, Ghanekar S, Diamandis Z, Acosta SA, Borlongan CV. Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol. 2017;158:94–131. https://doi.org/10.1016/j.pneurobio.2017.07.004.CrossRefPubMedPubMedCentral

89.

Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10(12):861–72. https://doi.org/10.1038/nrn2735.CrossRefPubMed

90.

Carmichael ST, Chesselet MF. Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002;22(14):6062–70 doi:20026605.CrossRef

91.

Dancause N, Barbay S, Frost SB, Plautz EJ, Chen D, Zoubina EV, et al. Extensive cortical rewiring after brain injury. J Neurosci. 2005;25(44):10167–79. https://doi.org/10.1523/JNEUROSCI.3256-05.2005.CrossRefPubMedPubMedCentral

92.

Brown CE, Aminoltejari K, Erb H, Winship IR, Murphy TH. In vivo voltage-sensitive dye imaging in adult mice reveals that somatosensory maps lost to stroke are replaced over weeks by new structural and functional circuits with prolonged modes of activation within both the peri-infarct zone and distant sites. J Neurosci. 2009;29(6):1719–34. https://doi.org/10.1523/JNEUROSCI.4249-08.2009.CrossRefPubMedPubMedCentral

93.

Jones TA, Schallert T. Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci. 1994;14(4):2140–52.CrossRefPubMedPubMedCentral

94.

Biernaskie J, Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J Neurosci. 2001;21(14):5272–80.CrossRefPubMedPubMedCentral

95.

Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res. 2006;84(7):1495–504. https://doi.org/10.1002/jnr.21056.CrossRefPubMedPubMedCentral

96.

Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol. 2009;216(1):47–55. https://doi.org/10.1016/j.expneurol.2008.11.010.CrossRefPubMed

97.

Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain. 2006;129(Pt 10):2734–45. https://doi.org/10.1093/brain/awl207.CrossRefPubMed

98.

Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience. 2005;136(1):161–9. https://doi.org/10.1016/j.neuroscience.2005.06.062.CrossRefPubMed

99.

Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013;70(20):3871–82. https://doi.org/10.1007/s00018-013-1290-8.CrossRefPubMed

100.

Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14(1):7–23. https://doi.org/10.1038/nrn3379.CrossRefPubMed

101.

Cramer SC, Chopp M. Recovery recapitulates ontogeny. Trends Neurosci. 2000;23(6):265–71.CrossRefPubMed

102.

• Zhang ZG, Chopp M. Exosomes in stroke pathogenesis and therapy. J Clin Investig. 2016;126(4):1190–7. https://doi.org/10.1172/JCI81133 Excellent review about a exosomes, and emerging field related to stem cells but beyond the scope of this current review. CrossRefPubMedPubMedCentral

103.

Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee IH, Lin WS, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013;8(8):e72604. https://doi.org/10.1371/journal.pone.0072604.CrossRefPubMedPubMedCentral

104.

Sheikh AM, Yano S, Mitaki S, Haque MA, Yamaguchi S, Nagai A. A mesenchymal stem cell line (B10) increases angiogenesis in a rat MCAO model. Exp Neurol. 2018;311:182–93. https://doi.org/10.1016/j.expneurol.2018.10.001.CrossRefPubMed

105.

Jin K, Xie L, Mao X, Greenberg MB, Moore A, Peng B, et al. Effect of human neural precursor cell transplantation on endogenous neurogenesis after focal cerebral ischemia in the rat. Brain Res. 2011;1374:56–62. https://doi.org/10.1016/j.brainres.2010.12.037.CrossRefPubMed

106.

Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G, et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain. 2011;134(Pt 6):1777–89. https://doi.org/10.1093/brain/awr094.CrossRefPubMedPubMedCentral

107.

Hou SW, Wang YQ, Xu M, Shen DH, Wang JJ, Huang F, et al. Functional integration of newly generated neurons into striatum after cerebral ischemia in the adult rat brain. Stroke. 2008;39(10):2837–44. https://doi.org/10.1161/STROKEAHA.107.510982.CrossRefPubMed

108.

Daadi MM, Lee SH, Arac A, Grueter BA, Bhatnagar R, Maag AL, et al. Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant. 2009;18(7):815–26. https://doi.org/10.3727/096368909X470829.CrossRefPubMed

109.

Martinez-Cerdeno V, Noctor SC, Espinosa A, Ariza J, Parker P, Orasji S, et al. Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell. 2010;6(3):238–50. https://doi.org/10.1016/j.stem.2010.01.004.CrossRefPubMedPubMedCentral

110.

Zhang R, Chopp M, Zhang ZG. Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci. 2013;7:201. https://doi.org/10.3389/fncel.2013.00201.CrossRefPubMedPubMedCentral

111.

Adams KL, Gallo V. The diversity and disparity of the glial scar. Nat Neurosci. 2018;21(1):9–15. https://doi.org/10.1038/s41593-017-0033-9.CrossRefPubMed

112.

Li Y, Liu Z, Xin H, Chopp M. The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke. Glia. 2014;62(1):1–16. https://doi.org/10.1002/glia.22585.CrossRefPubMed

113.

Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology. 2000;55(4):565–9.CrossRefPubMed

114.

Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg. 2005;103(1):38–45. https://doi.org/10.3171/jns.2005.103.1.0038.CrossRefPubMed

115.

Rabinovich SS, Seledtsov VI, Banul NV, Poveshchenko OV, Senyukov VV, Astrakov SV, et al. Cell therapy of brain stroke. Bull Exp Biol Med. 2005;139(1):126–8.CrossRefPubMed

116.

Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis. 2005;20(2):101–7. https://doi.org/10.1159/000086518.CrossRefPubMed

117.

Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874–82. https://doi.org/10.1002/ana.20501.CrossRefPubMed

118.

Suarez-Monteagudo C, Hernandez-Ramirez P, Alvarez-Gonzalez L, Garcia-Maeso I, de la Cuetara-Bernal K, Castillo-Diaz L, et al. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor Neurol Neurosci. 2009;27(3):151–61. https://doi.org/10.3233/RNN-2009-0483.CrossRefPubMed

119.

Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010;28(6):1099–106. https://doi.org/10.1002/stem.430.CrossRefPubMed

120.

Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70(1):59–69. https://doi.org/10.1002/ana.22458.CrossRefPubMed

121.

Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011;134(Pt 6):1790–807. https://doi.org/10.1093/brain/awr063.CrossRefPubMedPubMedCentral

122.

Friedrich MA, Martins MP, Araujo MD, Klamt C, Vedolin L, Garicochea B, et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant. 2012;21(Suppl 1):S13–21. https://doi.org/10.3727/096368912X612512.CrossRefPubMed

123.

Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Pinero P, Espigado I, et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke. 2012;43(8):2242–4. https://doi.org/10.1161/STROKEAHA.112.659409.CrossRefPubMed

124.

Bhasin A, Srivastava MV, Kumaran SS, Mohanty S, Bhatia R, Bose S, et al. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra. 2011;1(1):93–104. https://doi.org/10.1159/000333381.CrossRefPubMedPubMedCentral

125.

Bhasin A, Srivastava M, Bhatia R, Mohanty S, Kumaran S, Bose S. Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med. 2012;8(3):181–9.PubMedPubMedCentral

126.

Bhasin A, Srivastava MV, Mohanty S, Bhatia R, Kumaran SS, Bose S. Stem cell therapy: a clinical trial of stroke. Clin Neurol Neurosurg. 2013;115(7):1003–8. https://doi.org/10.1016/j.clineuro.2012.10.015.CrossRefPubMed

127.

Bhasin A, Kumaran SS, Bhatia R, Mohanty S, Srivastava MVP. Safety and feasibility of autologous mesenchymal stem cell transplantation in chronic stroke in Indian patients. A four-year follow up. J Stem Cells Regen Med. 2017;13(1):14–9.PubMedPubMedCentral

128.

Wang L, Ji H, Li M, Zhou J, Bai W, Zhong Z, et al. Intrathecal Administration of Autologous CD34 positive cells in patients with past cerebral infarction: a safety study. ISRN Neurol. 2013;2013:128591–6. https://doi.org/10.1155/2013/128591.CrossRefPubMedPubMedCentral

129.

Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. 2014;45(12):3618–24. https://doi.org/10.1161/STROKEAHA.114.007028.CrossRefPubMed

130.

Kalladka D, Sinden J, Pollock K, Haig C, McLean J, Smith W, et al. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet. 2016;388(10046):787–96. https://doi.org/10.1016/S0140-6736(16)30513-X.CrossRefPubMed

131.

•• Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, et al. Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study. Stroke; a journal of cerebral circulation. 2016;47(7):1817–24. https://doi.org/10.1161/STROKEAHA.116.012995 While interpretation is limited by the design as an uncontrolled study, this trial demonstrated clinically significant improvements in chronic stroke patients following stem cell transplantation. CrossRef

132.

Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. https://doi.org/10.1136/bmj.328.7454.1490.CrossRefPubMed

133.

Thomas RJ, Hope AD, Hourd P, Baradez M, Miljan EA, Sinden JD, et al. Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line. Biotechnol Lett. 2009;31(8):1167–72. https://doi.org/10.1007/s10529-009-9989-1.CrossRefPubMed

134.

Stevanato L, Corteling RL, Stroemer P, Hope A, Heward J, Miljan EA, et al. c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain. BMC Neurosci. 2009;10:86. https://doi.org/10.1186/1471-2202-10-86.CrossRefPubMedPubMedCentral

135.

Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke. 2008;39(10):2765–8. https://doi.org/10.1161/STROKEAHA.107.512269.CrossRefPubMedPubMedCentral

136.

Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L, et al. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke. 2011;42(3):825–9. https://doi.org/10.1161/STROKEAHA.110.601914.CrossRefPubMed

137.

•• Savitz SI, Cramer SC, Wechsler L, Consortium S. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke. 2014;45(2):634–9. https://doi.org/10.1161/STROKEAHA.113.003379 Consensus guidelines from the STEPS consortiums outlining best practices moving forward in the design of clinical trials for cell-based therapies. These guidelines are essential to ensure the quality of trials and the continued generation of mechanistic knowledge in the trial setting so that therapies can be refined and optimized based on clinical results. CrossRefPubMed

138.

Stem Cell Therapies as an Emerging Paradigm in Stroke P. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40(2):510–5. https://doi.org/10.1161/STROKEAHA.108.526863.CrossRef

139.

Bernstock JD, Peruzzotti-Jametti L, Ye D, Gessler FA, Maric D, Vicario N, et al. Neural stem cell transplantation in ischemic stroke: a role for preconditioning and cellular engineering. J Cereb Blood Flow Metab. 2017;37(7):2314–9. https://doi.org/10.1177/0271678X17700432.CrossRefPubMedPubMedCentral

140.

Chan SJ, Love C, Spector M, Cool SM, Nurcombe V, Lo EH. Endogenous regeneration: engineering growth factors for stroke. Neurochem Int. 2017;107:57–65. https://doi.org/10.1016/j.neuint.2017.03.024.CrossRefPubMed

141.

Madl CM, Heilshorn SC, Blau HM. Bioengineering strategies to accelerate stem cell therapeutics. Nature. 2018;557(7705):335–42. https://doi.org/10.1038/s41586-018-0089-z.CrossRefPubMedPubMedCentral

142.

•• Krakauer JW, Marshall RS. The proportional recovery rule for stroke revisited. Ann Neurol. 2015;78(6):845–7. https://doi.org/10.1002/ana.24537 Summarizes the concept of proportional recovery and discusses two studies which predict who may or may not follow this rule, providing a benchmark for expected spontaneous recovery against which stem cell therapies may be compared. CrossRefPubMed

Titel: Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies
verfasst von: Ania Dabrowski
Thomas J. Robinson
Ryan J. Felling
Publikationsdatum: 01.01.2019
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 1/2019
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-019-0920-4

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy

Research in the Acute Rehabilitation Setting: a Bridge Too Far?

CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD